CRISPR screen reveals cell cycle pathway as synthetic lethal partner for mTOR inhibition in HNSCC, suggesting dual blockade prevents adaptive resistance.
CRISPR screening identified cell cycle pathway as synthetic lethal pathway for mTORi in HNSCC
No takes yet. Share an insight, caveat, or question.
Goto et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: